Long-lasting changes in the processing of nociceptive information in the dorsal horn of the spinal cord may contribute to pathological pain sensation 1,2 . These changes mechanistically and phenotypically resemble hippocampus-dependent memory formation 3, 4 . The parallels discovered between hyperalgesia and memory raise the possibility that hyperalgesia may also exhibit a phenomenon similar to memory reconsolidation: a protein synthesis-dependent process by which memories are rendered labile after reactivation and susceptible to erasure 5, 6 . However, the existence of a process analogous to memory reconsolidation has not yet been observed outside defined memory systems in mammals. To address the possibility that such a process exists in pain pathways, we directly tested the hypothesis that hyperalgesia becomes labile and reversible after re-sensitization.
B r i e f c o m m u n i c at i o n s
Long-lasting changes in the processing of nociceptive information in the dorsal horn of the spinal cord may contribute to pathological pain sensation 1, 2 . These changes mechanistically and phenotypically resemble hippocampus-dependent memory formation 3, 4 . The parallels discovered between hyperalgesia and memory raise the possibility that hyperalgesia may also exhibit a phenomenon similar to memory reconsolidation: a protein synthesis-dependent process by which memories are rendered labile after reactivation and susceptible to erasure 5, 6 . However, the existence of a process analogous to memory reconsolidation has not yet been observed outside defined memory systems in mammals. To address the possibility that such a process exists in pain pathways, we directly tested the hypothesis that hyperalgesia becomes labile and reversible after re-sensitization.
We first administered an intraplantar injection of capsaicin (5 µl, 0.5%; Fig. 1a ) in the hind paw of mice to induce mechanical hyperalgesia that persisted for more than 6 h (Fig. 1b) and was dependent on spinal protein synthesis (Supplementary Fig. 1a) . The sensitized pain pathways were reactivated 3 h after the first capsaicin injection with a second, identical capsaicin (or vehicle) injection combined with an intrathecal injection of the protein synthesis inhibitor anisomycin (235 nmol) or vehicle. Anisomycin did not affect mechanical hyperalgesia when paired with intraplantar injection of vehicle, indicating that the hyperalgesia induced by the first capsaicin injection is well-established and insensitive to disruption by protein synthesis inhibition at that time. However, we observed a substantial reduction in hyperalgesia when the second injection of capsaicin was paired with anisomycin ( Fig. 1b,c) . The temporal window in which hyperalgesia is labile after the second injection of capsaicin was limited to less than 2 h after treatment, as intrathecal administration of anisomycin after this time did not reverse hyperalgesia ( Supplementary  Fig. 1b) . Similarly, pairing a second plantar injection of capsaicin with the systemic administration of anisomycin (100 mg per kg of body weight, intraperitoneal) also caused a robust inhibition of hyperalgesia ( Supplementary Fig. 1c,d) . Administration of another protein synthesis inhibitor, cycloheximide (175 nmol intrathecal), also reversed hyperalgesia when paired with a second injection of capsaicin (Supplementary Fig. 1e ). Thus, hyperalgesia is rendered labile and reversible after concurrent re-administration of capsaicin.
We next asked whether intense nociceptor activity, such as that induced by sensitizing stimuli 7 , is sufficient to render capsaicin-induced hyperalgesia labile. For this, we used an optogenetic mouse model in which channelrhodopsin is expressed in Nav1.8 + nociceptors 8, 9 (Nav1.8 + -ChR2). The injected paw was exposed 3 h after the induction of hyperalgesia by intraplantar capsaicin injection to low-frequency (2 Hz) optical stimulation that induces transient mechanical hyperalgesia 9 (Supplementary Fig. 1f ). The optogenetic reactivation of sensitized pain pathways rendered capsaicin-induced hyperalgesia labile and reversible, but did not modify mechanosensitivity in the absence of anisomycin administration (Fig. 1d,e) . Notably, the sensitivity of the Nav1.8 + -ChR2 mice to light did not change throughout the experiment in any treatment group (Supplementary Fig. 1g ).
To test whether the reversal of hyperalgesia is a permanent or temporary phenomenon, we examined whether hyperalgesia induced by Complete Freund's Adjuvant (CFA) can also be rendered labile. Plantar injection of CFA (10 µl) induced mechanical hyperalgesia that lasted for up to 8 d after injection (Fig. 1f ) . On the second day after CFA administration, anisomycin (235 nmol intrathecal) or vehicle was co-administered with intraplantar capsaicin or vehicle. The co-administration of anisomycin and capsaicin produced a persistent reduction of CFA-induced hyperalgesia that was evident 3 h after treatment (Fig. 1g) . Furthermore, the mechanical withdrawal thresholds of mice that received capsaicin and anisomycin returned to baseline within 2 d post-injection. In contrast, the CFA-induced hyperalgesia was unaffected by vehicle + anisomycin, vehicle + vehicle or capsaicin + vehicle injection 3 h after drug administration, and, in these treatment groups, a considerable degree of hyperalgesia was observed up to 8 d post-injection of CFA (Supplementary Table 1 ). These data indicate that co-administration of capsaicin and anisomycin not only reversed CFA-induced hyperalgesia, but also substantially reduced the recovery time from hyperalgesia. Thus, well-established hyperalgesia can be rendered labile and permanently reduced following re-sensitization.
The activation of nociceptors by capsaicin induces the release of glutamate and substance P from C fibers to induce hyperalgesia and sensitization of second-order neurons in the superficial dorsal horn (SDH) 10 . We tested whether the activation of spinal AMPA and NMDA receptors by glutamate and NK-1 receptors by substance P are necessary to render hyperalgesia labile following reactivation of the sensitized pain pathways. As before, the intrathecal administration of anisomycin paired with the plantar injection of capsaicin caused Hyperalgesia arising from sensitization of pain relays in the spinal dorsal horn shares many mechanistic and phenotypic parallels with memory formation. We discovered that mechanical hyperalgesia could be rendered labile and reversible in mice after reactivation of spinal pain pathways in a process analogous to memory reconsolidation. These findings reveal a previously unknown regulatory mechanism underlying hyperalgesia and demonstrate the existence of reconsolidationlike processes in a sensory system. Fig. 2c ), respectively, all prevented the reversal of hyperalgesia by anisomycin after re-administration of capsaicin (Fig. 2d) . The intrathecal administration of these antagonists without anisomycin had no effects on hyperalgesia (Fig. 2d) . Thus, the activation of AMPA, NMDA and NK-1 receptors are necessary to render hyperalgesia labile following re-administration of intraplantar capsaicin. These data further suggest that the erasure of hyperalgesia that we observed primarily involves synaptic activation of secondorder neurons in the SDH.
We next tested whether the direct activation of spinal AMPA, NMDA or NK-1 receptors is sufficient to render capsaicin-induced hyperalgesia labile without capsaicin re-administration. The intrathecal administration of AMPA (375 pmol), NMDA (375 pmol) or Sar9,Met(O 2 )11-substance P (25 pmol) alone all produced nocifensive responses immediately after intrathecal injection, but did not modulate capsaicin-induced hyperalgesia ( Supplementary  Fig. 1h-j) . The co-administration of AMPA or NMDA with anisomycin reversed hyperalgesia, whereas anisomycin co-administered with Sar9,Met(O 2 )11-substance P did not (Supplementary Fig. 1k ). These data further imply that 'reconsolidation' of hyperagesia is triggered by the strong activation of second-order neurons in pain processing pathways, and may involve mechanisms of synaptic plasticity. In support of this, spinal inhibition of CaMKII or ERK, key mediators of sensitization and plasticity in pain pathways 1 (Fig. 2e,f) . The transformation of hyperalgesia to a labile state without nociceptor activation raises the possibility that drug-induced hyperalgesia (for example, with opiates) may be similarly rendered labile or trigger lability despite the varied etiology of these pathologies 11, 12 . Synaptic plasticity is implicated in memory reconsolidation 13 . In a parallel to reconsolidation, late-phase synaptic long-term potentiation (LTP) in the in vitro hippocampal slice preparation can be disrupted by inhibiting protein synthesis only under conditions of ongoing synaptic activity 14 . We further explored the labile properties of synaptic plasticity in nociceptive pathways by inducing LTP in the SDH as an in vitro model of spinal sensitization 7 . The extracellularly recorded postsynaptic field potentials (fPSPs) evoked in the SDH of whole spinal cord preparations reflect the summation of postsynaptic responses that are mainly monosynaptically evoked in laminae I and II 15, 16 . A slow-rising, NMDA-dependent LTP (Supplementary Fig. 1l ) was induced by electrically stimulating dorsal roots at low frequency (2 Hz; Fig. 3a ) 17 , and the stimulus was repeated 3 h after the initial induction of LTP. The second stimulation alone did not change the magnitude of LTP (Fig. 3b) . However, the LTP was reversed when anisomycin was added to the bath for 2 h starting 30 min before the second stimulus (Fig. 3c) . These results confirm that synaptic plasticity in the SDH can become labile following reactivation in a manner similar to hyperalgesia.
The demonstration that hyperalgesia and SDH LTP can be erased through the same procedure provides evidence for a causal link between persistent pain and LTP of spinal nociceptive pathways 3, 7 . Taken together, these results indicate that hyperalgesia can be rendered labile at the spinal level and erased following reactivation in a process analogous to memory reconsolidation, and forge a crucial link to define hyperalgesia as a pathological pain 'memory' 3, 4, 18 . It remains to be tested whether spontaneous pain events per se are sufficient to trigger lability in certain chronic pain states. These data provide, to the best of our knowledge, the first demonstration of a reconsolidation-like phenomenon in a sensory system that is removed from established memory pathways, suggesting that reconsolidation exists more broadly throughout the CNS than previously known. We propose that exploiting the ability to render hyperalgesia labile may eventually provide a therapeutic strategy for the treatment and erasure of established, persistent pain.
MeTHodS
Methods and any associated references are available in the online version of the paper. Adult (>12 weeks old) male C57Bl/6 mice were used for experiments except where indicated otherwise. Mice were kept on a 12:12-h light:dark cycle in groups of 1-4 mice per cage with food and water provided ad libitum. All experiments were conducted on naive mice and started before 10:00. Mechanosensitivity was measured using the SUDO up-down method with von Frey hairs to estimate the 50% withdrawal threshold in pressure units (g mm −2 ) (ref. 19). Care was taken to avoid the injection site when testing mechanosensitivity. Mechanical hyperalgesia was induced by intraplantar injection of capsaicin (5 µl, 0.5%, wt/vol) and all intraplantar and intrathecal injections (5 µl) were performed under light (<3 min) isoflurane anesthesia 18 . Animals were randomly assigned to treatment groups and the experimenter was blinded during testing and data analysis. Mice were excluded if they did not exhibit a reduction in withdrawal threshold greater than 10% after sensitization. One mouse was excluded from the study (substance P + anisomycin group) based on this criterion. Behavioral data were analyzed as percentage of MPE using the formula 100%·(test 3 -test 1)·(baseline -test 1) −1 . For optogenetic studies of hyperalgesia, mice expressing ChR2 in Nav1.8 + nociceptive afferents (Nav1.8-ChR2) were generated by crossing mice expressing Cre recombinase in Nav1.8 + neurons (Nav1.8-Cre) 8 with mice expressing a loxP-flanked STOP cassette upstream of a ChR2-EYFP fusion gene at the Rosa 26 locus (Rosa-CAG-LSL-ChR2(H134R)-EYFP-WPRE; stock number 012569, Jackson Laboratory). In these mice, the vast majority (>90%) of Cre-expressing cells are unmyelinated C fibers, but not exclusively 8, 20 . Notably, the behavioral responses associated with manipulation of Nav1.8 + afferents are consistent with a predominantly nociceptive role for Nav1.8 + afferents 9, 21 . Nocifensive responses were elicited from Nav1.8-ChR2 mice by focally applying 488-nm light (iBeam Smart PT) with an optic fiber (200-µm core diameter, 0.22 NA) placed approximately 0.5 mm from the plantar surface of the hind paw. Threshold responses were measured by increasing the light intensity until a sharp flinching response from the light was observed within 1 s of the light application. Light output power from the laser was measured with a power meter (PM100, Thor Labs) and divided by the cross sectional area of the fiber core to determine light intensity. Sensitization was induced in Nav1.8-ChR2 mice by stimulating the hind paw of anesthetized mice with 488-nm light at a low frequency (2 Hz, 10-ms pulses) for 20 min as previously described 9 . The light intensity used for sensitization was 4-5-fold higher than threshold intensity. Anesthesia was induced with isoflurane at the minimum concentration required to prevent paw withdrawal from light stimulus (approximately 1.8%). Drugs were administered intrathecally just before stimulation. Mice in the sham stimulation group underwent the same anesthesia procedure, but received no stimulation of the hind paw with light. The experimenter was blinded to treatment group.
6-cyano-7-nitroquinoxaline-2,3-dione disodium salt (CNQX), d-(−)-2-amino-5-phosphonovaleric acid (AP5), (RS)-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), N-Methyl-d-aspartic acid (NMDA), CP-99994 dihydrochloride, Sar 9 ,Met(O 2 ) 11 -substance P, cycloheximide, FR-180204, KN-93 and anisomycin were dissolved in saline vehicle for intrathecal or intraperitoneal injection. Capsaicin was dissolved in a vehicle solution containing 10% ethanol, 10% Tween (Sigma-Aldrich), and 80% saline (vol/vol). All drugs and chemicals used in behavioral experiments were purchased from Tocris Cookson except where otherwise specified.
electrophysiology. Electrophysiological recordings of dorsal root-evoked postsynaptic field potentials (fPSPs) were made using a whole spinal cord tissue preparation. Adult male C57Bl/6 mice were anesthetized with urethane (2 g per kg) and perfused with ice-cold sucrose-substituted artificial cerebral spinal fluid (aCSF; 252 mM sucrose, 2.5 mM KCl, 1.5 mM CaCl 2 , 6 mM MgCl 2 , 10 mM d-glucose, bubbled with 95%/5% oxygen/CO 2 ). The lumbar spinal column was removed and immersed in ice-cold sucrose aCSF, after which the whole lumbar spinal cord was quickly removed via laminectomy. Ventral roots and connective tissue were removed from the spinal cord and the tissue was placed in 20-22 °C aCSF (126 mM NaCl, 2.5 mM KCl, 2 mM CaCl 2 , 2 mM MgCl 2 , 10 mM d-glucose, bubbled with 95%/5% oxygen/CO 2 ) for 1 h before experimentation. During experiments, the tissue was perfused with aCSF at 20-22 °C at a flow rate of 8-10 ml min −1 .
fPSPs were recorded via a borosilicate glass electrode inserted into the dorsal side of the spinal cord in the dorsal root entry zone. Electrodes were inserted superficially to a depth of no more than 125 µm from the dorsal surface of the spinal cord measured with an MPC-200 manipulator (Sutter Instrument). Electrodes had a tip resistance of 3−4 MOhm when filled with aCSF. fPSPs were evoked by electrical stimulation of the dorsal root using a suction electrode that is pulled from borosilicate glass and filled with aCSF, and placed near the cut end of the dorsal root. Field potentials were amplified with a Multiclamp 700B amplifier (Molecular Devices), digitized with a Digidata 1322A (Molecular Devices), and recorded using pClamp 10 software (Molecular Devices). Data were filtered during acquisition with a low pass filter set at 1.6 kHz and sampled at 10 kHz.
Test stimuli were presented every 60 s to evoke fPSPs. The stimulus intensity was sufficient to activate C fibers, as indicated by the appearance of a third distinct fiber volley after the stimulus artifact, whereas a slightly (10−20%) higher intensity was used to induce LTP. Evidence that the fPSPs are largely dependent on C fibers is given by the similarities between fPSPs evoked by electrical stimulation of the dorsal root or optogenetic activation of Nav1.8 + fibers 9 . Notably, optogenetic activation of Nav1.8 + afferents produces a similar LTP to that produced by electrical stimulation of dorsal roots 9 . LTP was induced by lowfrequency stimulation of the dorsal root (2 Hz, 2 min) as described previously 17 . This LTP likely reflects an increase in the net postsynaptic activation of superficial dorsal horn neurons, as supraspinally projecting neurons only comprise a small percentage of the neurons in this area 22 . After a stable baseline recording (30 min), LTP stimuli were presented at time = 0 min and 180 min (in some experiments). Where indicated, anisomycin (100 µM) was added to the aCSF at 150 min and washed out at 270 min for a total application of 2 h. In some experiments, AP5 was added to the perfusion solution 10 min before the induction of LTP and washed out immediately after the stimulation protocol. The 10-min period immediately before the addition of AP5 was used for baseline in these experiments. Data were analyzed using ClampFit 10 software (Molecular Devices). The area of fPSPs relative to baseline was measured from 0−800 ms after the onset of the fPSP. All drugs and chemicals for electrophysiology experiments were purchased from Sigma-Aldrich.
